Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study. - Wikidata - awgldk - TriplyDB

Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

http://www.wikidata.org/entity/Q33651579

about

Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa Magnitude of cytopenias among HIV-infected children in Bahir Dar, northwest Ethiopia: a comparison of HAART-naïve and HAART-experienced children Antiretroviral treatment in HIV-infected infants and young children: novel issues raised by the Mississippi baby Aetiology and management of malnutrition in HIV-positive children.Challenges in infant and young child nutrition in the context of HIV Weight as predictors of clinical progression and treatment failure: results from the TREAT Asia Pediatric HIV Observational Database Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement Predictors of mortality among children on Antiretroviral Therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study.Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study Anaemia in HIV-infected children: severity, types and effect on response to HAART.Factors associated with antiretroviral treatment interruption in human immunodeficiency virus (HIV)-1-infected children attending the Jos University Teaching Hospital, Jos, Nigeria.Prevalence and risk factors of undernutrition among antiretroviral-therapy-naïve subjects aged under 5 years old in Makurdi, Nigeria: a retrospective study.Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz.Severe malnutrition and metabolic complications of HIV-infected children in the antiretroviral era: clinical care and management in resource-limited settings.Effect of Age at Antiretroviral Therapy Initiation on Catch-up Growth Within the First 24 Months Among HIV-infected Children in the IeDEA West African Pediatric Cohort.[Impact of antiretroviral therapy on the biological profile of HIV positive children followed-up at Yaounde University Hospital in Cameroon].Growth reconstitution following antiretroviral therapy and nutritional supplementation: systematic review and meta-analysis.CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States.The long-term effectiveness of generic adult fixed-dose combination antiretroviral therapy for HIV-infected Ugandan children.Immunological Response of Hiv-Infected Children to Highly Active Antiretoviral Therapy at Gondar University Hospital, North-Western Ethiopia Unresolved antiretroviral treatment management issues in HIV-infected children Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic.Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia.Factors Determining Survival and Retention among HIV-Infected Children and Adolescents in a Community Home-Based Care and a Facility-Based Family-Centred Approach in Kampala, Uganda: A Cohort Study.Growth failure and nutrition considerations in chronic childhood wasting diseases.Hematologic abnormalities and associated factors among HIV infected children pre- and post-antiretroviral treatment, North West Ethiopia.Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation.Growth Recovery Among HIV-infected Children Randomized to Lopinavir/Ritonavir or NNRTI-based Antiretroviral Therapy.Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda.Growth in HIV-infected children on long-term antiretroviral therapy.Quantification of CD4 responses to combined antiretroviral therapy over 5 years among HIV-infected children in Kinshasa, Democratic Republic of Congo High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia.HIV viral suppression and longevity among a cohort of children initiating antiretroviral therapy in Eastern Cape, South Africa

P2860

Q21261820-54979456-7E01-4D76-9828-46F3B5406C47 Q24197527-B188053B-9C17-4333-B028-DFF115673AE0 Q28546698-249CFDCF-7323-4889-8238-9765E8F1827B Q33439843-379ABA06-1AFB-42C0-9391-74FA9DBE5B7E Q33557037-753A0D6C-712F-4BF8-ACF0-74F0ABFFDFF9 Q33659087-FE3960C9-4895-4C14-9DC4-3036AA297408 Q34006870-344A53F5-8CBC-46A8-87B0-58F9E3AF8655 Q34051420-F18BD7AD-7D92-484C-A1FC-753F360E4627 Q34374033-AFBE2E84-30F2-45DA-B63B-EF2AC1DA49F8 Q34435987-954B3054-BD59-41FD-9297-594EE3E87E96 Q34445856-2696CF62-206C-4172-AF1B-53B7F7197062 Q34462882-46162EA6-3FB2-4F9D-9534-8F09038BF8B0 Q35041658-1B2F1C4B-2377-4DB5-8465-143C6E89E238 Q35284462-495712E8-A443-42A3-9990-6B4F0CD9BF96 Q35547048-7AB23F6A-8E46-43BD-8E36-79AB8C6243A3 Q35578704-8A05ECFC-D202-4507-A7B8-90B2AB950C57 Q35738443-CBE40FC0-3201-4C6F-88EA-5A2F89420221 Q35748231-F6EDA390-692C-4EAE-977F-AD3EFF5CB518 Q36084809-1E33542A-370F-4C70-A989-D7F2B79D6569 Q36180809-582A48FF-4157-4D09-93DC-AD03D28D7281 Q36569791-243964EF-80F1-494D-A8FA-766EAC672278 Q36605248-4671BAE5-8DAC-4263-95D7-FAFDDE0B75CE Q36781481-EA553BA9-ED5C-4676-B9C8-A6BDB8DD36AC Q36807963-E2C335CB-9299-4F3D-9544-318A9E71B775 Q37322060-A932CC5E-31C1-47B2-B13D-F28AEBA04976 Q37681409-8ECCAADD-076E-445F-B832-07E5CF3A061C Q37730863-08836F0A-5CF7-4C30-974A-5C8CCB86C53F Q38265982-D890F289-88DF-4B4E-A53F-5E8E1BBCD68D Q38613220-EB4F2F54-55CA-4911-9E22-752615DCFF1C Q38660444-5F037019-FBC2-426C-838E-2BD7412AEB57 Q38853193-35F7B734-F5AA-4EFC-97DA-4787728347A3 Q38869702-891E951A-41C6-4A07-92D2-51813BA15FFD Q40355257-5506A256-BF8D-4322-B30C-9458AC31621A Q41381835-650CF4B4-E971-4056-B61B-158124127754 Q47547186-B604F58F-FF98-43CA-867E-41C5BBAE8FE6 Q56938270-18BA5E6F-96AC-487C-B603-240BD965F42F

P2860

Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

http://www.wikidata.org/entity/Q33651579

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Growth, immune and viral respo ...... y: a prospective cohort study.

@ast

Growth, immune and viral respo ...... y: a prospective cohort study.

@en

type

label

Growth, immune and viral respo ...... y: a prospective cohort study.

@ast

Growth, immune and viral respo ...... y: a prospective cohort study.

@en

prefLabel

Growth, immune and viral respo ...... y: a prospective cohort study.

@ast

Growth, immune and viral respo ...... y: a prospective cohort study.

@en

P1433

Q33651579-8AE9929D-F703-42C9-93B1-32FEBB3D0F7E

P1476

Q33651579-7327EA5E-1F54-40A8-9FEB-8B37CB7B1568

P2093

Q33651579-2D58FCE8-869A-48B2-9990-015512326EFC

Q33651579-3D58DAB2-808E-4C3F-8025-85602892B771

Q33651579-4C401E06-5442-4807-B2C8-B3B437B1598C

Q33651579-729093E2-42E6-4740-BAAF-E50FC960D223

Q33651579-920D1FC4-A2F2-4F5C-8B8F-5E0FA60C8556

Q33651579-A6345899-C95A-4B9D-B4BA-C52C1401BCC6

Q33651579-B7A7507A-7BDC-4AA2-B0A1-4E6369142722

Q33651579-D8BFAA54-631B-4572-B08E-8958C7346176

P2860

Q33651579-137CF37B-5E88-490B-B557-C0A06E33CB21

Q33651579-337A790A-5BBD-4692-AE92-3D816039B038

Q33651579-344D0E35-0EE7-43D5-95D6-12CD3AE1E029

Q33651579-38D3165F-F872-42D3-8430-99E7B9F96FFC

Q33651579-39E3C018-C48B-4378-BCB7-DEE25096F4BB

Q33651579-3B2DA9A7-4FCC-422F-BD24-1080018A5BA4

Q33651579-44C35E84-047D-465E-B997-EAA00CEB246D

Q33651579-4EE2D1D4-6942-4A76-8F40-47CAB7E2D65D

Q33651579-52F2C3A3-2E15-4773-A1DA-05E24B8A20FE

Q33651579-5855E45F-8C1F-4D69-81AA-CC553EE48D3A

P2888

Q33651579-0CB4755A-574C-4772-BB6D-20B7038633A9

P304

Q33651579-056EC1CE-B3D8-4109-AEEF-6FB2AB3D7F9F

P31

Q33651579-870E12C1-2022-46D6-AAA2-B1D814551BFF

P356

Q33651579-DFBFB49A-DDEA-4F80-AD49-E67849CC09F2

P478

Q33651579-B7388E9A-225B-4D22-A66B-A9699E5E22FC

P50

Q33651579-C1E4C75C-0923-464E-9583-F351D3473BFA

P577

Q33651579-E4F3AF9D-D582-48AC-A815-08A0B1080A0B

P5875

Q33651579-22EDE812-79A8-4843-8A45-A8F711F2A4B0

P6179

Q33651579-C66AD6CE-CA1C-4324-8AE4-3CE7C37CAC2F

P698

Q33651579-5F76CFEE-03D7-45AA-9B79-098FD9C4EA6C

P921

Q33651579-91E399A0-D419-4FF4-A88D-C5D6B41EF595

P932

Q33651579-FF20E42C-3950-4BE6-AB99-8A2238250501

P356

1471-2431-10-56

P1433

P1476

Growth, immune and viral respo ...... y: a prospective cohort study.

@en

P2093

Danstan Bagenda

http://www.w3.org/2001/XMLSchema#string

Linda N Barlow-Mosha

http://www.w3.org/2001/XMLSchema#string

Mary G Fowler

http://www.w3.org/2001/XMLSchema#string

Michael M Mubiru

http://www.w3.org/2001/XMLSchema#string

Patrick Ajuna

http://www.w3.org/2001/XMLSchema#string

Peter Mudiope

http://www.w3.org/2001/XMLSchema#string

Philippa M Musoke

http://www.w3.org/2001/XMLSchema#string

Thorkild Tylleskar

http://www.w3.org/2001/XMLSchema#string

P2860

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

Growth failure in children with HIV infection.

The emergence and epidemiology of resistance in the nucleoside-experienced HIV-infected population.

Nutritional aspects of HIV-infected children receiving highly active antiretroviral therapy.

Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children.

Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.

HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis.

Response to antiretroviral therapy in HIV-infected Ugandan children exposed and not exposed to single-dose nevirapine at birth.

Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.

Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda.

P2888

1471-2431-10-56

P304

56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2431-10-56

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Thorkild Tylleskär

P577

2010-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45535677

http://www.w3.org/2001/XMLSchema#string

P6179

1007934415

http://www.w3.org/2001/XMLSchema#string

P698

20691045

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2923128

http://www.w3.org/2001/XMLSchema#string